1. Concomitant use of opioids and serotonergic medicines: risk of serotonin syndrome

   News item 17 September 2022 Pages: 1 - 1

2. Donepezil-related QT prolongation and torsades de points

   News item 17 September 2022 Pages: 2 - 2

3. Drugs associated with DRESS should be titrated slowly to reduce risk

   News item 17 September 2022 Pages: 3 - 3

4. Fake Viagra and Cialis seized in Canada

   News item 17 September 2022 Pages: 4 - 4

5. PRAC meeting highlights August 2022

   News item 17 September 2022 Pages: 5 - 5

6. SPIKEVAX and SPIKEVAX Bivalent have same colour vial cap

   News item 17 September 2022 Pages: 6 - 6

7. SSRI-associated suicidality in children and adolescents

   News item 17 September 2022 Pages: 7 - 7

8. Beta-blocker use during pregnancy lowers birthweight

   Clinical study 17 September 2022 Pages: 8 - 8

9. COVID-19 outcome not worsened by remdesivir-induced bradycardia

   Clinical study 17 September 2022 Pages: 9 - 9

10. Immune checkpoint inhibitor-related type 1 diabetes

    Clinical study 17 September 2022 Pages: 10 - 10

11. Managing DILI and paracetamol hepatotoxicity in paediatric patients

    Clinical study 17 September 2022 Pages: 11 - 11

12. Serious AEs of special interest after mRNA COVID-19 vaccination

    Clinical study 17 September 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 17 September 2022 Pages: 13 - 13

14. Influenza-A-virus-vaccine-H1N1

    Case report 17 September 2022 Pages: 14 - 14

15. Abiraterone acetate/prednisone

    Case report 17 September 2022 Pages: 15 - 15

16. Acarbose

    Case report 17 September 2022 Pages: 16 - 16

17. Acetazolamide

    Case report 17 September 2022 Pages: 17 - 17

18. Aciclovir/diazepam/valproic-acid

    Case report 17 September 2022 Pages: 18 - 18

19. Ad26.cov2-s

    Case report 17 September 2022 Pages: 19 - 19

20. Ad26.COV2-S

    Case report 17 September 2022 Pages: 20 - 20

21. Ad26.COV2-S/AZD-1222/tozinameran

    Case report 17 September 2022 Pages: 21 - 21

22. Adalimumab

    Case report 17 September 2022 Pages: 22 - 22

23. Adalimumab

    Case report 17 September 2022 Pages: 23 - 23

24. Adalimumab/etanercept

    Case report 17 September 2022 Pages: 24 - 24

25. Adalimumab/infliximab

    Case report 17 September 2022 Pages: 25 - 25

26. Adefovir/entecavir/lamivudine

    Case report 17 September 2022 Pages: 26 - 26

27. Afatinib/gefitinib/osimertinib

    Case report 17 September 2022 Pages: 27 - 27

28. Aflibercept

    Case report 17 September 2022 Pages: 28 - 28

29. Aflibercept/bevacizumab/metoprolol

    Case report 17 September 2022 Pages: 29 - 29

30. Agerafenib

    Case report 17 September 2022 Pages: 30 - 30

31. Alcohol

    Case report 17 September 2022 Pages: 31 - 31

32. Alendronic-acid/zoledronic-acid

    Case report 17 September 2022 Pages: 32 - 32

33. Alirocumab

    Case report 17 September 2022 Pages: 33 - 33

34. Allopurinol/venetoclax

    Case report 17 September 2022 Pages: 34 - 34

35. Alpelisib

    Case report 17 September 2022 Pages: 35 - 35

36. Alpha-beta-adrenergic-receptor-antagonists/spironolactone

    Case report 17 September 2022 Pages: 36 - 36

37. Alteplase

    Case report 17 September 2022 Pages: 37 - 37

38. Amikacin/azithromycin/omadacycline

    Case report 17 September 2022 Pages: 38 - 38

39. Amikacin/ciprofloxacin

    Case report 17 September 2022 Pages: 39 - 39

40. Amiodarone

    Case report 17 September 2022 Pages: 40 - 40

41. Amiodarone/metoprolol

    Case report 17 September 2022 Pages: 41 - 41

42. Amiodarone/prazosin

    Case report 17 September 2022 Pages: 42 - 42

43. Amlodipine/hydrochlorothiazide/losartan

    Case report 17 September 2022 Pages: 43 - 43

44. Amoxicillin

    Case report 17 September 2022 Pages: 44 - 44

45. Amphotericin-B

    Case report 17 September 2022 Pages: 45 - 45

46. Amphotericin-B liposomal/caspofungin

    Case report 17 September 2022 Pages: 46 - 46

47. Analgesics/duloxetine

    Case report 17 September 2022 Pages: 47 - 47

48. Andexanet-alfa/anticoagulants/prothrombin complex concentrate

    Case report 17 September 2022 Pages: 48 - 48

49. Anti-inflammatories

    Case report 17 September 2022 Pages: 49 - 49

50. Antibacterials

    Case report 17 September 2022 Pages: 50 - 50